Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Rebecca Tushnet
False advertising and more
Rebecca Tushnet
Rebecca Tushnet
Email subscription
ABA Blawg 100
Posts
Subscribe via RSS or LinkedIn
"Bright young [wo]man"/"Yo, who the F is this?"
Blog Archive
-
▼
2012
(598)
-
▼
April
(45)
- eBay and injunctions
- Message in (on) a bottle
- Niche fame
- Political remix video
- New tip: don't use promotions as a cover for legal...
- Watch the MPAA grit its teeth
- Is a Facebook app inherently commercial promotion?
- Settlement agreement not specific enough to bar sl...
- Publishing exec: why I break DRM
- No "lack of substantiation" claim under Cal. law
- New stromboli in old boxes
- challenge to "innovative" claim isn't barred by Da...
- TM Scholars' Roundtable part 3
- TM roundtable part 2
- Culture of linking
- Fourth Trademark Scholars Roundtable: Boundary Pro...
- OTW fundraising drive
- Highly limited "healthy fats" claim survives dismi...
- The apotheosis of appropriation?
- latest entry in the "licensed parody" category
- Creative Commons in China
- Sometimes Rogers v. Grimaldi goes down a bit hard
- Intellectual Property at the Edge Part 3
- Intellectual Property at the Edge part 2
- Intellectual Property at the Edge part 1
- Fordham: last one! ECJ and copyright
- Fordham IP: TM developments
- Fordham IP: TM and functionality
- Fordham IP: Copyright: a view from the EU
- Fordham IP: copyright and music
- Fordham IP session: copyright
- Julie Cohen's excellent book
- Fordham IP law and policy conference
- Disaffirming kids' iTunes purchases
- Another big Lanham Act damages award
- The alloy of law
- Plaintiff is going to want a stiff drink with this...
- Rare "no interstate commerce" Lanham Act case
- Rule 9(b) applies to Lanham Act claims; nasty C&D ...
- Today's quick TM read
- investor class certified in Coldwell Banker false ...
- Knowing defamation of plaintiff insufficient for p...
- "authentic" and "scientists" not enough to convert...
- Lanham Act recognizes agency liability, not aiding...
- quick bit on Skydive Arizona and surveys
-
▼
April
(45)
Labels
- 1201 (19)
- 1202 (2)
- 230 (96)
- acpa (16)
- advertising (283)
- antitrust (49)
- arbitration (3)
- art law (36)
- attribution (28)
- b (1)
- blogging (23)
- california (538)
- can-spam (1)
- cfaa (12)
- cfps (53)
- class actions (278)
- cmi (19)
- comics (37)
- commercial speech (273)
- conferences (930)
- consumer protection (970)
- content moderation (3)
- contracts (101)
- copying (195)
- copyright (1664)
- counterfeiting (1)
- creative commons (12)
- cultural property (10)
- cybersquatting (1)
- damages (161)
- dastar (197)
- defamation (203)
- derivative works (2)
- design patent (57)
- dilution (257)
- disclosures (101)
- disparagement (32)
- dmca (203)
- drm (72)
- evidence (1)
- false advertising (3136)
- false association (13)
- false designation of origin (7)
- false endorsement (13)
- fan fiction (87)
- fanworks (190)
- fda (275)
- fees (35)
- first amendment (445)
- ftc (185)
- g (1)
- geographic indications (43)
- go (1)
- google (89)
- insurance (72)
- interviews (5)
- jobs (2)
- jurisdiction (5)
- libraries (18)
- misappropriation (10)
- moral rights (18)
- music (137)
- my lawsuits (16)
- my writings (114)
- net neutrality (5)
- parody (27)
- patent (226)
- patents (136)
- peer production (27)
- preclusion (1)
- preemption (270)
- presentations (119)
- privacy (113)
- procedure (146)
- property (18)
- reading list (311)
- remedies (282)
- right of publicity (267)
- secondary liability (178)
- securities (8)
- standing (357)
- surveys (109)
- teaching (38)
- tortious interference (116)
- trade secrets (81)
- trademark (2068)
- traditional knowledge (11)
- unconscionability (5)
- unfairness (64)
- warranties (14)
Things I've read
Creative Commons/disclaimer
Text on this blog is licensed under a Creative Commons Attribution 2.5 License. Pictures and works quoted may be subject to other parties' copyrights.
I speak for myself. On this blog, I do not and cannot speak for Harvard Law School, the Organization for Transformative Works and/or AO3.
No comments:
Post a Comment